Table 1
Characteristic (n = 12) | T0 | T3 | T6 |
|---|---|---|---|
Age, years | 50 (33–67) | NA | NA |
Current smoking, n | 3/12 | NA | NA |
Male/Female, n | 9/3 | NA | NA |
Current CD4 cells/μL | 312 (91–1650) | 348 (132–1664) | 476 (234–1908) |
Current CD4 % | 25 (7–55) | 24 (11–52) | 26 (21–53) |
CD38+CD8+ % | 1 (0–47) | 1 (1–4) | 2 (1–3) |
CD38+CD8+ n | 21 (0–42) | 23 (10–69) | 33 (12–46) |
CD95+CD4+ % | 2 (1–9) | 1 (0–4) | 1 (1–1) |
CD95+CD4+ n | 26 (12–270) | 21 (0–42) | 19 (12–36) |
CD95+CD8+ % | 2 (1–10) | 2 (1–6) | 1 (1–2) |
CD95+CD8+ n | 31 (17–130) | 30 (14–63) | 22 (13–36) |
CD127+CD8+ % | 14 (9–24) | 13 (5–28) | 12 (5–25) |
CD127+CD8+ n | 269 (78–480) | 208 (65–588) | 218 (75–580) |
TNF-alpha, pg/ml | 2.7 (0.9–5.1) | ND | 2.6 (1.7–8.9) |
IL-6, pg/ml | 1.4 (0–6.5) | ND | 1.4 (0.5–3) |
Total cholesterol, mg/dL | 225 (154–301) | 246 (159–339) | 241 (186–366) |
LDL cholesterol, mg/dL | 133 (76–401) | 50 (82–505) | 53 (32–74) |
Tryglicerides, mg/dL | 136 (90–571) | 169 (36–923) | 227 (132–1137) |
Homocysteinemia, mg/dL | 12 (4.6–23.5) | ND | 11 (3.4–17.4) |
IMT, mm right carotid | ND | ND | 0.99 (0.79–1.49) |
IMT, mm left carotid | ND | ND | 0.99 (0.82–1.61) |
IMT, mm right femoral | ND | ND | 0.96 (0.83–1.24) |
IMT, mm left femoral | ND | ND | 1.01 (0.92–1.75) |
Current HIV-RNA, Log10/mL | 1,77 (1,77–4,3) | 1,77 (1,77–2.4) | 1,77 (1,77–3.9) |